Attached files
| file | filename |
|---|---|
| 10-Q - AETHLON MEDICAL, INC. FORM 10-Q - AETHLON MEDICAL INC | aethlon_10q-123109.htm |
| EX-10.7 - SECURED PROMISSORY NOTE - AETHLON MEDICAL INC | aethlon_10q-ex1007.htm |
| EX-10.1 - CONVERTIBLE NOTE - AETHLON MEDICAL INC | aethlon_10q-ex1001.htm |
| EX-31.1 - CERTIFICATION - AETHLON MEDICAL INC | aethlon_10q-ex3101.htm |
| EX-10.6 - WARRANT TO PURCHASE STOCK - AETHLON MEDICAL INC | aethlon_10q-ex1006.htm |
| EX-10.5 - CONVERTIBLE PROMISSORY NOTE - AETHLON MEDICAL INC | aethlon_10q-ex1005.htm |
| EX-10.4 - SECURITIES PURCHASE AGREEMENT - AETHLON MEDICAL INC | aethlon_10q-ex1004.htm |
| EX-10.3 - FIRST AMENDMENT TO LEASE - AETHLON MEDICAL INC | aethlon_10q-ex1003.htm |
| EX-10.2 - COMMON STOCK PURCHASE WARRANT - AETHLON MEDICAL INC | aethlon_10q-ex1002.htm |
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Aethlon Medical, Inc. on Form 10-Q for
the fiscal quarter ended December 31, 2009 as filed with the Securities and
Exchange Commission on the date hereof, I, James A. Joyce, Chief Executive
Officer and Chief Accounting Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:
1. Based
on my knowledge, the Quarterly Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended,
and
2. The
information contained in such Quarterly Report on Form 10-Q fairly presents, in
all material respects, the financial condition and results of operations of
Aethlon Medical, Inc.
Date:
February 16, 2010
|
By:
|
/s/ James A. Joyce | |
| James A. Joyce | ||
| Chief Executive Officer and Chief Accounting Officer | ||
A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to Aethlon Medical, Inc. and will be retained
by Aethlon Medical, Inc. and furnished to the Securities and Exchange Commission
or its staff upon request.